The fate of the bioeconomy in Europe remains undecided. The evaluation of the European Commission’s bioeconomy...
Up To Date
Latest News
Austrian Apeiron Biologics has outlicensed the global marketing rights for its neuroblastoma...
Danish insulin maker Novo Nordisk tries to relieve financial pressure by laying off 1,000 staff. The step was...
CAR T cell specialist bluebird bio has inked a potential US$1bn partnership with Medigene – to get access to...
Martinsried-based autoimmune specialist Immunic AG secured financial support for the next 3.5 years from lead...
Backed by MPM Capital and Sofinnova, immuno-oncology specialist iOmx Therapeutics has raised €40m in its first...